|
|
Hui Jin, Aparna Aiyer, Jingmei Su, Per Borgstrom, Dwayne Stupack, Martin Friedlander, Judy Varner
J Clin Invest. 2006;
116(3):652
doi:10.1172/JCI24751
Abstract |
Full text
| PDF
| Supplemental material
C
D34+ bone marrow–derived progenitor cells contribute to tissue repair by differentiating into endothelial cells, vascular smooth muscle cells, hematopoietic cells, and possibly other cell types. However, the mechanisms by which circulating progenitor cells home to remodeling tissues remain unclear. Here we show that integrin α4β1 (VLA-4) promotes the homing of circulating progenitor cells to the α4β1 ligands VCAM and cellular fibronectin, which are expressed on actively remodeling neovasculature. Progenitor cells, which express integrin α4β1, homed to sites of active tumor neovascularization but not to normal nonimmune tissues. Antagonists of integrin α4β1, but not other integrins, blocked the adhesion of these cells to endothelia in vitro and in vivo as well as their homing to neovasculature and outgrowth into differentiated cell types. These studies describe an adhesion event that facilitates the homing of progenitor cells to the neovasculature.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(67)
| Title and authors |
Publication |
Year |
From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma
Vladimir Ratushny, Michael D. Gober, Ryan Hick, Todd W. Ridky, John T. Seykora
|
J. Clin. Invest.
|
2012 |
Abnormal tumor vasculatures and bone marrow-derived pro-angiogenic cells in cancer
Yusuke Mizukami, Junpei Sasajima, Toshifumi Ashida, Yutaka Kohgo
|
Int J Hematol
|
2012 |
A novel treatment for glioblastoma: integrin inhibition
Marc C Chamberlain, Timothy Cloughsey, David A Reardon, Patrick Y Wen
|
Expert Rev Neurotherapeutics
|
2012 |
Integrins and bone metastasis: Integrating tumor cell and stromal cell interactions
Jochen G. Schneider, Sarah R. Amend, Katherine N. Weilbaecher
|
Bone
|
2011 |
Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies
David A Reardon, Bart Neyns, Michael Weller, Joerg Christian Tonn, Louis Burt Nabors, Roger Stupp
|
Future Oncology
|
2011 |
Hematopoietic Stem Cell Homing to Injured Tissues
Dean Philip John Kavanagh, Neena Kalia
|
Stem Cell Rev and Rep
|
2011 |
Interventional Cardiology
Zoë Astroulakis, Alex Sirker, Jonathan M. Hill
|
Interventional Cardiology
|
2011 |
In VitroManipulation of Endothelial Progenitor Cell Adhesion to Vascular Endothelium and Extracellular Matrix by the Phorbol Ester PMA
Maciej Powerski, Dirk Henrich, Anna Sander, Anna Teiler, Ingo Marzi
|
Artif Cells Blood Substit Immobil Biotechnol
|
2011 |
Towards expansion of human hair follicle stem cells in vitro
J. H. Oh, P. Mohebi, D. L. Farkas, J. Tajbakhsh
|
Cell Proliferation
|
2011 |
Homing of Progenitor Cells to Ischemic Tissues
Emmanouil Chavakis, Stefanie Dimmeler
|
Antioxidants & Redox Signaling
|
2011 |
|